Non-clinical services for development of interventional agents for infectious diseases
Ended Awarded Last action
- Contract number
- 75N93024F00004
- Awardee
-
Sri International UEI SRG2J1WS9X63
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $260,145
Award facts
- Contract value 25% obligated
-
- $260,145.00 Current, with exercised options
- $1,023,969.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Menlo Park, CA 94025, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Original award | $260,145 |
About this award
This is a federal contract award from the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to SRI International, a non-profit research and development institute. The contract is for $1,023,969.00 to provide non-clinical services for the development of interventional agents for infectious diseases. The contract has a period of performance through April 30, 2025 and was awarded on August 30, 2024. This contract is a delivery order under a larger Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle called "Nonclinical Services for Development of Interventional Agents." SRI International has a subcontractor, Charles River Laboratories, Inc., performing a rat embryo-fetal study under this award. The contract does not utilize any set-aside designations.
Quick answers
Who was awarded contract 75N93024F00004?
75N93024F00004 was awarded to Sri International by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 30, 2024.
How much is contract 75N93024F00004 worth?
The government has obligated $260,145 on 75N93024F00004. Its potential value, with all options, is $1,023,969.
Is contract 75N93024F00004 an order under another contract?
Yes. 75N93024F00004 is a delivery order under 75N93018D00001, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93024F00004 competed?
The extent of competition for 75N93024F00004 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award